These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 32975881)

  • 1. Production, Processing, and Characterization of Synthetic AAV Gene Therapy Vectors.
    El Andari J; Grimm D
    Biotechnol J; 2021 Jan; 16(1):e2000025. PubMed ID: 32975881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution.
    Grimm D; Büning H
    Hum Gene Ther; 2017 Nov; 28(11):1075-1086. PubMed ID: 28835125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boosters for adeno-associated virus (AAV) vector (r)evolution.
    Szumska J; Grimm D
    Cytotherapy; 2023 Mar; 25(3):254-260. PubMed ID: 35999132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation AAV vectors for clinical use: an ever-accelerating race.
    Weinmann J; Grimm D
    Virus Genes; 2017 Oct; 53(5):707-713. PubMed ID: 28762205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering and evolution of synthetic adeno-associated virus (AAV) gene therapy vectors via DNA family shuffling.
    Kienle E; Senís E; Börner K; Niopek D; Wiedtke E; Grosse S; Grimm D
    J Vis Exp; 2012 Apr; (62):. PubMed ID: 22491297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants.
    Weinmann J; Weis S; Sippel J; Tulalamba W; Remes A; El Andari J; Herrmann AK; Pham QH; Borowski C; Hille S; Schönberger T; Frey N; Lenter M; VandenDriessche T; Müller OJ; Chuah MK; Lamla T; Grimm D
    Nat Commun; 2020 Oct; 11(1):5432. PubMed ID: 33116134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation AAV vectors-do not judge a virus (only) by its cover.
    Domenger C; Grimm D
    Hum Mol Genet; 2019 Oct; 28(R1):R3-R14. PubMed ID: 31261383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Assembly-Activating Protein on Molecular Evolution of Synthetic Adeno-Associated Virus Capsids.
    Herrmann AK; Große S; Börner K; Krämer C; Wiedtke E; Gunkel M; Grimm D
    Hum Gene Ther; 2019 Jan; 30(1):21-35. PubMed ID: 29978729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine-learning-guided Directed Evolution for AAV Capsid Engineering.
    Fu X; Suo H; Zhang J; Chen D
    Curr Pharm Des; 2024; 30(11):811-824. PubMed ID: 38445704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.
    Grimm D; Lee JS; Wang L; Desai T; Akache B; Storm TA; Kay MA
    J Virol; 2008 Jun; 82(12):5887-911. PubMed ID: 18400866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing.
    de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA
    Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breaking the sound barrier: Towards next-generation AAV vectors for gene therapy of hearing disorders.
    Fakhiri J; Landegger LD; Grimm D
    Hear Res; 2022 Jan; 413():108092. PubMed ID: 33268240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Robust and All-Inclusive Pipeline for Shuffling of Adeno-Associated Viruses.
    Herrmann AK; Bender C; Kienle E; Grosse S; El Andari J; Botta J; Schürmann N; Wiedtke E; Niopek D; Grimm D
    ACS Synth Biol; 2019 Jan; 8(1):194-206. PubMed ID: 30513195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants.
    Rapti K; Maiakovska O; Becker J; Szumska J; Zayas M; Bubeck F; Liu J; Gerstmann E; Krämer C; Wiedtke E; Grimm D
    J Vis Exp; 2022 Oct; (188):. PubMed ID: 36342179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
    Chamberlain K; Riyad JM; Weber T
    Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy.
    Rodríguez-Márquez E; Meumann N; Büning H
    Expert Opin Biol Ther; 2021 Jun; 21(6):749-766. PubMed ID: 33331201
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the adeno-associated virus capsid in gene transfer.
    Van Vliet KM; Blouin V; Brument N; Agbandje-McKenna M; Snyder RO
    Methods Mol Biol; 2008; 437():51-91. PubMed ID: 18369962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale.
    Lock M; Alvira M; Vandenberghe LH; Samanta A; Toelen J; Debyser Z; Wilson JM
    Hum Gene Ther; 2010 Oct; 21(10):1259-71. PubMed ID: 20497038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus Vectors.
    Lam AK; Frabutt D; Li L; Xiao W
    Hum Gene Ther; 2021 Dec; 32(23-24):1433-1438. PubMed ID: 34254844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioengineered Hybrid Rep 2/6 Gene Improves Encapsulation of a Single-Stranded Expression Cassette into AAV6 Vectors.
    Tejero M; Duzenli OF; Caine C; Kuoch H; Aslanidi G
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.